955 related articles for article (PubMed ID: 2849052)
21. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
[TBL] [Abstract][Full Text] [Related]
22. Pharmacologic evidence for 5-HT1A receptors associated with human retinal pigment epithelial cells in culture.
Nash MS; Osborne NN
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):510-9. PubMed ID: 9040484
[TBL] [Abstract][Full Text] [Related]
23. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
[TBL] [Abstract][Full Text] [Related]
24. Involvement of 5-hydroxytryptamine7 receptors in inhibition of porcine myometrial contractility by 5-hydroxytryptamine.
Kitazawa T; Kubo O; Satoh M; Taneike T
Br J Pharmacol; 1998 Jan; 123(2):173-82. PubMed ID: 9489604
[TBL] [Abstract][Full Text] [Related]
25. Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor.
Conner DA; Mansour TE
Mol Pharmacol; 1990 May; 37(5):742-51. PubMed ID: 2338946
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor.
Craig DA; Clarke DE
J Pharmacol Exp Ther; 1990 Mar; 252(3):1378-86. PubMed ID: 2319473
[TBL] [Abstract][Full Text] [Related]
27. Recombinant saphenous vein 5-HT1B receptors of the rabbit: comparative pharmacology with human 5-HT1B receptors.
Wurch T; Palmier C; Colpaert FC; Pauwels PJ
Br J Pharmacol; 1997 Jan; 120(1):153-9. PubMed ID: 9117091
[TBL] [Abstract][Full Text] [Related]
28. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
29. Characterization of 5-hydroxytryptamine-induced relaxations of guinea-pig proximal colon.
Kojima S
Arch Int Pharmacodyn Ther; 1991; 313():23-32. PubMed ID: 1816762
[TBL] [Abstract][Full Text] [Related]
30. Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Brüss M; Kiel S; Bönisch H; Kostanian A; Göthert M
Neurochem Int; 2005 Aug; 47(3):196-203. PubMed ID: 15896881
[TBL] [Abstract][Full Text] [Related]
31. 5-Hydroxytryptamine-receptor subtypes.
Brodde OE
Clin Physiol Biochem; 1990; 8 Suppl 3():19-27. PubMed ID: 2132174
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives.
Bockaert J; Sebben M; Dumuis A
Mol Pharmacol; 1990 Mar; 37(3):408-11. PubMed ID: 2314390
[TBL] [Abstract][Full Text] [Related]
33. Identification and classification of 5-HT1 receptor subtypes.
Göthert M; Schlicker E
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S1-7. PubMed ID: 1702482
[TBL] [Abstract][Full Text] [Related]
34. Characterization of serotonin-1B receptors negatively coupled to adenylate cyclase in OK cells, a renal epithelial cell line from the opossum.
Murphy TJ; Bylund DB
J Pharmacol Exp Ther; 1989 May; 249(2):535-43. PubMed ID: 2542534
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.
De Vivo M; Maayani S
J Pharmacol Exp Ther; 1986 Jul; 238(1):248-53. PubMed ID: 2941565
[TBL] [Abstract][Full Text] [Related]
36. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
37. Evidence for involvement of 5-hydroxytryptamine1 receptors in antidepressant-like drug effects on differential-reinforcement-of-low-rate 72-second behavior.
Marek GJ; Li AA; Seiden LS
J Pharmacol Exp Ther; 1989 Jul; 250(1):60-71. PubMed ID: 2746511
[TBL] [Abstract][Full Text] [Related]
38. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.
Schoeffter P; Hoyer D
Br J Pharmacol; 1988 Nov; 95(3):975-85. PubMed ID: 3207999
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological characterization of a 5-hydroxytryptamine-sensitive receptor/adenylate cyclase complex in the mandibular closer muscles of the cricket, Gryllus domestica.
Baines RA; Downer RG
Arch Insect Biochem Physiol; 1991; 16(3):153-63. PubMed ID: 1665996
[TBL] [Abstract][Full Text] [Related]
40. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
Aulakh CS; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
